Incyte (INCY) Equity Ratio (2010 - 2026)
Incyte posted quarterly Equity Ratio of 0.77 for Q1 2026, up 20.1% year-on-year from 0.64 in Q1 2025, and up 3.16% on a QoQ basis from 0.74 in Q4 2025.
Incyte (INCY) has 17 years of Equity Ratio data on file, last reported at 0.77 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio rose 20.1% year-over-year to 0.77; the trailing twelve-month figure through Mar 2026 stood at 0.77 (up 20.1% YoY), and the FY2025 full-year result was 0.74, up 17.28% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.77, up from 0.74 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.77 in Q3 2023 and bottomed at 0.63 in Q3 2024.
- The 5-year median for Equity Ratio is 0.76 (2024), against an average of 0.73.
- The widest annual swing landed in 2024, when Equity Ratio slipped 18.04%; it then grew 20.1% in 2026.
- A 5-year view of Equity Ratio shows it stood at 0.75 in 2022, then climbed by 2.28% to 0.77 in 2023, then declined by 17.25% to 0.63 in 2024, then advanced by 17.28% to 0.74 in 2025, then gained by 3.16% to 0.77 in 2026.
- The last three Equity Ratio figures came in at 0.77 (Q1 2026), 0.74 (Q4 2025), and 0.73 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.21 |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 0.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.77 |
| Dec 31, 2025 | 0.74 |
| Sep 30, 2025 | 0.73 |
| Jun 30, 2025 | 0.72 |
| Mar 31, 2025 | 0.64 |
| Dec 31, 2024 | 0.63 |
| Sep 30, 2024 | 0.63 |
| Jun 30, 2024 | 0.64 |
| Mar 31, 2024 | 0.76 |
| Dec 31, 2023 | 0.77 |
| Sep 30, 2023 | 0.77 |
| Jun 30, 2023 | 0.76 |
| Mar 31, 2023 | 0.77 |
| Dec 31, 2022 | 0.75 |
| Sep 30, 2022 | 0.77 |
| Jun 30, 2022 | 0.77 |
| Mar 31, 2022 | 0.76 |
| Dec 31, 2021 | 0.76 |
| Sep 30, 2021 | 0.75 |
| Jun 30, 2021 | 0.75 |
| Mar 31, 2021 | 0.75 |
| Dec 31, 2020 | 0.73 |
| Sep 30, 2020 | 0.72 |
| Jun 30, 2020 | 0.73 |
| Mar 31, 2020 | 0.70 |
| Dec 31, 2019 | 0.76 |
| Sep 30, 2019 | 13.86 |
| Jun 30, 2019 | 0.76 |
| Mar 31, 2019 | 0.76 |
| Dec 31, 2018 | 0.73 |
| Sep 30, 2018 | 0.72 |
| Jun 30, 2018 | 0.72 |
| Mar 31, 2018 | 0.71 |
| Dec 31, 2017 | 0.71 |
| Sep 30, 2017 | 0.74 |
| Jun 30, 2017 | 0.63 |
| Mar 31, 2017 | 0.60 |
| Dec 31, 2016 | 0.26 |
| Sep 30, 2016 | 0.24 |
| Jun 30, 2016 | 0.21 |
| Mar 31, 2016 | 0.21 |
| Dec 31, 2015 | 0.17 |
| Sep 30, 2015 | 0.10 |
| Jun 30, 2015 | 0.06 |
| Mar 31, 2015 | -0.05 |
| Dec 31, 2014 | -0.10 |
| Sep 30, 2014 | -0.11 |
| Jun 30, 2014 | -0.25 |
| Mar 31, 2014 | -0.24 |
| Dec 31, 2013 | -0.31 |
| Sep 30, 2013 | 0.08 |
| Jun 30, 2013 | -0.08 |
| Mar 31, 2013 | -0.50 |
| Dec 31, 2012 | -0.53 |
| Sep 30, 2012 | -0.74 |
| Jun 30, 2012 | -0.70 |
| Mar 31, 2012 | -0.85 |
| Dec 31, 2011 | -0.69 |
| Sep 30, 2011 | -0.49 |
| Jun 30, 2011 | -0.33 |
| Mar 31, 2011 | -0.23 |
| Dec 31, 2010 | -0.18 |